Calcitums Trademark Details

Calcitums was registered on Tuesday, November 30, 1993 and is currently owned by Glaxosmithkline LLC under the registration number 1807004 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 8 years ago on Friday, February 19, 2016, according to the United State Patent & Trademark Office
Word Mark Calcitums
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Glaxosmithkline LLC of Wilmington, DE

View all trademarks for Glaxosmithkline LLC
Other Trademarks for Glaxosmithkline LLC

Previous Owners

Smithkline Beecham Corporation of Philadelphia, PA

View all trademarks for Smithkline Beecham Corporation
Other Trademarks for Smithkline Beecham Corporation
Serial Number 74259699
Registration Number 1807004
Status Date Friday, February 19, 2016
Filing Date Friday, February 19, 2016
Registration Date Tuesday, November 30, 1993
Attorney Terence A. Dixon

Correspondent

Terence A. Dixon
GLAXOSMITHKLINE
LGTM - FP2030
One Franklin Plaza, 200 North 16th St.
Philadelphia PA 19102-1225

Case File Statements

Description of Mark The mark consists of the letters "CALCITUMS" and the representation of a partially opened roll of tablets.
Goods & Services Antacid Preparation
Lining/Stippling Statement The drawing is not lined for color.
Pseudo Mark Calcium Tums

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, February 19, 2016
First Use Anywhere Saturday, February 1, 1992
First Use In Commerce Saturday, February 1, 1992
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.